|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.28 USD | -1.18% |
|
-7.69% | -63.98% |
| Dec. 03 | Top Midday Decliners | MT |
| Dec. 03 | Acadia Healthcare's Downward Guidance Revision Due to Rising Liability Expenses, RBC Says | MT |
| Capitalization | 1.32B 1.12B 1.05B 986M 1.82B 119B 1.98B 12.24B 4.75B 56.25B 4.94B 4.84B 205B | P/E ratio 2025 * |
23.3x | P/E ratio 2026 * | 7.7x |
|---|---|---|---|---|---|
| Enterprise value | 3.51B 2.99B 2.79B 2.63B 4.84B 318B 5.28B 32.59B 12.64B 150B 13.17B 12.89B 547B | EV / Sales 2025 * |
1.07x | EV / Sales 2026 * | 1.02x |
| Free-Float |
96.99% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Acadia Healthcare Company, Inc.
More recommendations
More press releases
More news
| 1 day | -1.18% | ||
| 1 week | -7.69% | ||
| Current month | -16.98% | ||
| 1 month | -10.86% | ||
| 3 months | -34.28% | ||
| 6 months | -32.74% | ||
| Current year | -63.98% |
| 1 week | 13.6 | 14.7 | |
| 1 month | 12.63 | 17.58 | |
| Current year | 12.63 | 47.08 | |
| 1 year | 12.63 | 47.08 | |
| 3 years | 12.63 | 87.77 | |
| 5 years | 12.63 | 89.85 | |
| 10 years | 11.09 | 89.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2022-04-10 | |
Todd Young
DFI | Director of Finance/CFO | 54 | 2025-10-26 |
Stephanie Eken
CTO | Chief Tech/Sci/R&D Officer | - | 2024-04-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Reeve Waud
CHM | Chairman | 61 | 2018-12-15 |
William Grieco
BRD | Director/Board Member | 71 | 2011-03-31 |
Wade Miquelon
BRD | Director/Board Member | 60 | 2012-01-18 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.18% | -7.69% | -64.88% | -83.25% | 1.32B | ||
| +0.50% | -0.40% | +54.42% | +98.11% | 111B | ||
| -1.74% | +5.01% | +60.87% | -21.12% | 101B | ||
| +2.91% | +2.60% | +40.37% | +89.57% | 31.44B | ||
| -1.78% | -1.02% | -14.68% | +11.04% | 24.07B | ||
| -0.21% | +2.24% | +13.87% | +14.55% | 21.9B | ||
| +0.55% | +0.03% | +17.78% | +20.81% | 20.31B | ||
| +1.65% | +2.04% | +67.79% | +76.68% | 18.33B | ||
| +0.85% | -5.05% | +45.86% | +334.71% | 17.52B | ||
| -0.88% | -3.67% | +18.78% | +70.14% | 13.91B | ||
| Average | +0.09% | -0.90% | +24.02% | +61.13% | 36.02B | |
| Weighted average by Cap. | -0.07% | +1.01% | +44.30% | +57.42% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.29B 2.81B 2.62B 2.47B 4.54B 298B 4.96B 30.6B 11.87B 141B 12.36B 12.1B 513B | 3.44B 2.93B 2.74B 2.58B 4.75B 312B 5.18B 31.98B 12.4B 147B 12.92B 12.65B 536B |
| Net income | 59.54M 50.72M 47.38M 44.58M 82.07M 5.39B 89.66M 553M 215M 2.54B 223M 219M 9.27B | 173M 147M 138M 129M 238M 15.66B 260M 1.61B 623M 7.38B 649M 635M 26.94B |
| Net Debt | 2.19B 1.87B 1.74B 1.64B 3.02B 198B 3.3B 20.35B 7.89B 93.55B 8.22B 8.05B 341B | 2.18B 1.86B 1.73B 1.63B 3B 197B 3.28B 20.25B 7.85B 93.07B 8.18B 8.01B 340B |
More financial data
* Estimated data
Employees
22,346
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 14.28 $ | -1.18% | 2,068,857 |
| 25-12-11 | 14.45 $ | +5.09% | 4,645,657 |
| 25-12-10 | 13.75 $ | -1.86% | 2,095,556 |
| 25-12-09 | 14.01 $ | +0.07% | 2,523,439 |
| 25-12-08 | 14.00 $ | -9.50% | 2,983,825 |
Delayed Quote Nasdaq, December 12, 2025 at 04:00 pm EST
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
14.28USD
Average target price
21.57USD
Spread / Average Target
+51.06%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ACHC Stock
Select your edition
All financial news and data tailored to specific country editions
















